Key issues in the modes of action and effects of trichloroethylene metabolites for liver and kidney tumorigenesis

Environmental Health Perspectives

Volumn 114, Issue 9, 2006, Pages 1457-1463

  Caldwell, Jane C ^a   Keshava, Nagalakshmi ^a  

^a U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

Chloral hydrate; Dichloroacetic acid; S (1,2 dichlorovinyl) L cysteine; Trichloroacetic acid; Trichloroethanol; Trichloroethylene

Indexed keywords

CHLORAL HYDRATE; DICHLOROACETIC ACID; DNA; FORMIC ACID; S (1,2 DICHLOROVINYL)CYSTEINE; TRICHLOROACETIC ACID; TRICHLOROETHYLENE;

CANCER CELL; CANCER RISK; CONCENTRATION RESPONSE; CYTOTOXICITY; DNA METHYLATION; HUMAN; HYPOTHESIS; KIDNEY CANCER; LIVER CANCER; LIVER CARCINOGENESIS; MEDICAL LITERATURE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SIGNAL TRANSDUCTION;

ANIMALS; CARCINOGENICITY TESTS; CHLORAL HYDRATE; CYSTEINE; DICHLOROACETATE; ENVIRONMENTAL POLLUTANTS; HISTORY, 21ST CENTURY; HUMANS; KIDNEY NEOPLASMS; LIVER NEOPLASMS; RISK ASSESSMENT; RISK FACTORS; SIGNAL TRANSDUCTION; TRICHLOROACETIC ACID; TRICHLOROETHYLENE; UNITED STATES;

ANIMALIA;

EID: 33748185237     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.8692     Document Type: Review

References (77)

1. Adami HO, Chow WH, Nyrene O, Berne C, Linet MS, Ekbom A, et al 1996. Excess risk of primary liver cancer in patients with diabetes mellitus. J Natl Cancer Inst 88:1472-1477.
2. Ammini CV, Fernandez-Canon J, Shroads AL, Cornett R, Cheung J, James MO, et al. 2003. Pharmacologic or genetic ablation of maleylacetoacetate isomerase increases levels of toxic tyrosine catabolites in rodents. Biochem Pharmacol 66: 2029-2038.
3. Ballestar E, Esteller M. 2002. The impact of chromatin in human cancer: linking DNA methylation to gene silencing. Carcinogenesis 23:1103-1109.
4. Bannasch P. 1996. Pathogenesis of hepatocellular carcinoma: sequential cellular, molecular, and metabolic changes. Prog Liver Dis 16:161-197.
5. Bannasch P. 2001. Hormonal and hormone-like effects eliciting hepatocarcinogenesis. Folia Histochem Cytobiol 39(suppl 2): 28-29.
6. Bannasch P, Haertel T, Su O. 2003. Significance of hepatic preneoplasia in risk identification and early detection of neoplasia. Toxicol Pathol 31:134-139.
7. Bannasch P, Nehrbass D, Kopp-Schneider A 2001 Significance of hepatic preneoplasia for cancer chemoprevention. IARC Sci Publ 154:223-240.
8. Berger J, Daxenbichler G. 2002. DNA methylation of nuclear receptor genes - possible role in malignancy. J Steroid Biochem Mol Biol 80:1-11.
9. Bergeron A, Jorquera R, Tanguay RM. 2003. La tyrosinémie héréditare: unemaladie du stress du reticulum endoplasmique? [in French]. Med Sci (Paris) 19(10):976-980.
10. Blackburn AC, Coggan M, Tzeng HF, Lantum H, Polekhina G, Parker MW, et al. 2001. GSTZ1d: a new allele of glutathione transterase zeta and maleylacetoacetate isomerase Pharmacogenetics 11:671-678.
11. Blackburn AC, Tzeng HF, Anders MW, Board PG. 2000. Discovery of a functional polymorphism in human glutathione transferase zeta by expressed sequence tag database analysis Pharmacogenetics 10:49-57.
12. Board PG, Chelvanayagam G, Jermiin LS, Tetlow N, Tzeng HF, Anders MW, et al. 2001. Identification of novel glutathione transferases and polymorphic variants by expressed sequence tag database analysis. Drug Metab Dispos 29(4 pt 2) 544-547.
13. Bull RJ. 2004. Trichloroethylene and liver tumors in mice. In. Proceedings of New Scientific Research Related to the Health Effects of Trichlorothylene, 26-27 February 2004, Washington DC. Washington, DC:U.S. Environmental Protection Agency. Available: http://cfpub epa.gov/ ncea/cfm/recordisply.cfm?deid=75934 [accessed 3 August 2006].
14. Bull RJ, Orner GA, Cheng RS, Stillwell L, Stauber AJ, Sasser LB, et al. 2002. Contribution of dichloroacetate and trichloroacetate to liver tumor induction in mice by trichloroethylene Toxicol Appl Pharmacol 182:55-65.
15. Bull RJ, Sasser LB, Lei XC. 2004. Interactions in the tumor-promoting activity of carbon tetrachloride, trichloroacetate, and dichloroacetate in the liver of male B6C3F1 mice. Toxicology 199:169-183.
16. Carter JH, Carter HW, Deddens JA, Hurst BM, George MH, DeAngelo AB. 2003. A 2-year dose-response study of lesion sequences during hepatocellular carcinogenesis in the male B6C3F1 mouse given the drinking water chemical dichloroacetic acid. Environ Health Perspect 111:53-64.
17. Chen Y, Cai J, Anders MW, Stevens JL, Jones DP. 2001. Role of mitichondrial dysfunction in S-[1,2-dichlorovinyl)-L-cysteine-induced apoptosis. Toxicol Appl Pharmacol 170:172-180.
18. Chiu WA, Caldwell JC, Keshava N, Scott CS. 2006a. Key scientific issues in the health risk assessment of trichloroethylene Environ Health Perspect 114:1445-1449.
19. Chiu WA, Okino M, Lipscomb JC, Evans MV. 2006b. Issues in the pharmacokinetics of trichloroethylene and its metabolites Environ Health Perspect 114:1450-1456.
20. Cornett R, James MO, Henderson GN, Cheung J, Shroads AL, Stacpoole PW. 1999. Inhibition of glutathione S-transferase zeta and tyrosine metabolism by dichloroacetate: a potential unifying mechanism for its altered biotransformation and toxicity. Biochem Biophys Res Commum 262(3):752-756.
21. Cummings BS, Zangar RC, Novak RF, Lash LH. 2000. Cytotoxicity of trichloroethylene and S-(1,2-dichlorovinyl)-L-cysteine in primary cultures of rat renal proximal tubular and distal tubular cells. Toxicology 150:83-98.
22. DeAngelo AB, George MH, House DE. 1999. Hepatocarcinogenicity in the male B6C3F1 mouse following a lifetime exposure to dichloroacetic acid in the drinking water: dose-response determination and modes of action. J Toxicol Environ Health 58:485-507.
23. 12 and folate deficiency leads to increased formic acid excretion in the rat. Toxicology 146(2-3):123-136.
24. Evert M, Schneider-Stock R, Dombrowski F. 2005. Overexpression of fatty acid synthase in chemically and hormonally induced hepatocarcinogenesis of the rat, Lab Invest 85: 99-108.
25. Fraga MF, Ballestar E, Villar-Garea A, Boix-Chornet M, Espada J, Schotta G, et al. 2005. Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer. Nat Genet 37:391-400.
26. Fraga MF, Herranz M, Espada J, Ballestar E, Paz MF, Ropero S, et al. 2004. A mouse skin multistage carcinogenesis model reflects the aberrant DNA methylation patterns of human tumors. Cancer Res 64:5527-5534.
27. Furstenberger G, Senn HJ. 2002. Insulin-like growth factors and cancer. Lancet Oncol 3:298-302.
28. Ge R, Tao L, Kramer PM, Cunningham ML, Pereira MA. 2002. Effect of peroxisome proliferators on the methylation and protein level of the c-myc protooncogene in B6C3F1 mice liver. J Biochem Mol Toxicol 16:41-47.
29. Ge R, Yang S, Kramer PM, Too L, Pereira MA. 2001. The effect of dichloroacetic acid and trichloroacetic acid on DNA mothylation and cell proliferation in B6C3F1 mice. J Biochem Mol Toxicol 15:100-106.
30. George MH, Moore T, Kilburn S, Olson GR, DeAngelo AB. 2000 Carcinogenicity of chloral hydrate administered in drinking water to the male F344/N rat and male B6C3F1 mouse Toxicol Pathol 28:610-618.
31. Green T, Dow J, Foster J. 2003. Increased formic acid excretion and the development of kidney toxicity in rats following chronic dosing with trichloraethanol, a major metabolite of trichloroethylene. Toxicology 191:109-119.
32. Green T, Dow J, Ong CN, Ng V, Ong HY, Zhuang ZX, et al. 2004 Biological monitoring of kidney function among workers occupationally exposed to trichloroethylene. Occup Environ Med 61:312-317.
33. Herman JG, Umar A, Polyak K, Graff JR, Ahuja N, Issa JP, et al 1998. Incidence and functional consequences of hMLH1? promoter hypermethylation in colorectal carcinoma. Proc Natl Acad Sci USA 95(12):6870-6785.
34. Ho YS, Ma HY, Chang HY, Wei BL, Lee CC, Ho SY, et al. 2003 Lipid peroxidation and cell death mechanisms in rats and human cells induced by chloral hydrate. Food Chem Toxicol 41:621-629.
35. Jorquera R, Tanguay RM. 2001. Fumarylacetoacetate, the metabolite accumulating in hereditary tyrosinemia, activates the ERK pathway and induces mitotic abnormalities and genomic instability. Hum Mol Genet 10:1741-1752.
36. Keshava N, Caldwell JC. 2006. Key issues in the role of peroxisome proliferator activated receptor agonism and cell signaling in trichloroethylene toxicity. Environ Health Perspect 114:1464-1470.
37. Khandwala HM, McCutcheon IE, Flyvbjerg A, Friend KE. 2000. The effects of insulin-like growth factors on tumorogenesis and neoplastic growth. Endocr Rev 21(3)215-244.
38. Kim SZ, Kupke KG, Ierandi-Curto L, Holme E, Greter J, Tanguay RM, et al. 2000. Hepatocellular carcinoma despite long-term survival in chronic tyrosinaemia I. J Inherit Metab Dis 23:791-804.
39. Krause RJ, Lash LH, Elfarra AA. 2003. Human kidney flavin-containing monooxygenases and their potential roles in cysteine S-conjugate metabolism and nephrotoxicity. J Pharmacol Exp Ther 304:185-191.
40. Lash LH, Hueni SE, Putt DA. 2001. Apoptosis, necrosis, and cell proliferation induced by S-(1,2-dichlorovinyl)-L-cysteine in primary cultures of human proximal tubular cells. Toxicol Appl Pharmacol 177(1):1-16.
41. Lash LH, Parker JC, Scott CS. 2000. Mode of action of trichloroethylene for kidney tumorigenesis. Environ Health Perspect 108(suppl 2):225-240.
42. Lash LH, Putt DA, Hueni SE, Horwitz BP. 2005. Molecular markers of trichloroethylene-induced toxicity in human kidney cells. Toxicol Appl Pharmacol 206(2):157-168.
43. Lash LH, Putt DA, Hueni SE, Krause RJ, Elfarra AA. 2003. Roles of necrosis, apoptosis, and mitochondrial dysfunction in S-(1,2-dichlorovinyl)-L-cysteine sulfoxide-induced cytotoxicity in primary cultures of human renal proximal tubular cells. J Pharmacol Exp Ther 305(3):1163-1172.
44. LaVecchia C, Negri E, Franceschi S, D'Avanzo B, Boyle P. 1994. A case-control study of diabetes mellitus and cancer risk. Br J Cancer 70:950-953.
45. Leakey JE, Seng JE, Latendresse JR, Hussain N, Allen LJ, Allaben WT. 2003. Dietary controlled carcinogenicity study of chloral hydrate in male B6C3F1 mice. Toxicol Appl Pharmacol 193(2): 266-280.
46. Lingohr MK, Bull RJ, Kato-Weinstein J, Thrall BD. 2002. Dichloroacetate stimulates glycogen accumulation in primary hepatocytes through an insulin-independent mechanism. Toxicol Sci 68(2):508-515.
47. Lingohr MK, Thrall ED, Bull RJ. 2001. Effects of dichloroacetate (DCA) on serum insulin levels and insulin-controlled signaling proteins in livers of male B6C3F1 mice. Toxicol Sci 59(1):178-184.
48. Miller RT, Cattley RC, Marsman DS, Lyght O, Popp JA. 1995, TGF alpha differentially expressed in liver foci induced by diethylnitrosamine initiation and peroxisome proliferator promotion. Carcinogenesis 16:77-82.
49. Nehrbass D, Klimek F, Bannasch P. 1998. Overexpression of insulin receptor substrate-1 emerges early in hepatocarcinogenesis and elicits preneoplastic hepatic glycogenosis. Am J Pathol 152:341-345.
50. Nehrbass D, Klimek F, Bannasch P, Mayer D. 1999. Insulin receptor substrate-1 is over-expressed in glycogenotic but not in amphophilic preneoplastic hepatic foci induced in rats by N-nitrosomorpholine and dehydroepiandrosterone. Cancer Lett 140:75-79.
51. Nony PA, Schnellmann RG. 2001. Interactions between collagen IV and collagen-binding integrins in renal cell repair after sublethal injury. Mol Pharmacol 60:1226-1234.
52. Nony PA, Schnellmann RG. 2003. Mechanisms of renal cell repair and regeneration after acute renal failure. J Pharmocol Exp Ther 304:905-912.
53. Nowak G 2003. Protein kinase C mediates repair of mitochondrial and transport functions after toxicant-induced injury in renal cells. J Pharmacol Exp Ther 306:157-165
54. Pereira MA. 1996. Carcinogenic activity of dichloroacetic acid and trichloroacetic acid in the liver of female B6C3F1 mice. Fundam Appl Toxicol 31(2):192-199.
55. Pereira MA, Wang W, Kramer PM, Tao L 2004. DNA hypomethylation induced by non-genotoxic carcinogens in mouse and rat colon. Cancer Lett 212(2):145-151.
56. Rake JP, Visser G, Labrune P, Leonard JV, Ullrich K, Smit GP. 2002. Glycogen storage disease type I: diagnosis, management, clinical course and outcome. Results of the European Study on Glycogen Storage Disease Type I (ESGSD I). Eur J Pediatr 161(suppl 1):S20-S34.
57. Rhee I, Bachman KE, Park BH, Jair KW, Yen RW, Schuebel KE, et al. 2002. DNMT1 and DNMT3b cooperate to silence genes in human cancer cells. Nature 416(6880):552-556.
58. Scharf JG, Dombrowski F, Ramadori G. 2001. The IGF axis and hopatocarcinogenesis, Mol Pathol 54:138-144.
59. Schultz IR, Merdink JL, Gonzalez-Leon A, Bull RJ. 2002. Dichloroacetate toxicokinetics and disruption of tyrosine catabolism in B6C3F1 mice: dose-response relationships and age as a modifying factor. Toxicology 173:229-247.
60. Scott CS, Chiu WA. 2006. Trichloroethylene cancer epidemiology: a consideration of selected issues. Environ Health Perspect 114:1471-1478.
61. Seng JE, Agrawal N, Horsley ET, Leakey TI, Scherer EM, Xia S, et al. 2003. Toxicokinetics of chloral hydrate in ad libitumfed, dietary-controlled, and calorically restricted male B6C3F1 mice following short-term exposure. Toxicol Appl Pharmacol 193:281-292.
62. Su Q, Bannasch P. 2003. Relevance of hepatic preneoplasia for human hepatocarcinogenesis. Toxicol Pathol 31:126-133
63. Takeda S, Kondo M, Kumada T, Koshikawa T, Ueda R, Nishio M, et al 1995. Allelic-expression imbalance of the insulin-like growth factor 2 gene in hepatocellular carcinoma and underlying disease. Oncogene 2(7):1589-1592
64. Tanguay RM, Jorquera R, Poudrier J, St-Louis M. 1996. Tyrosine and its catabolites: from disease to cancer. Acta Biochem Pol 43:209-216.
65. Tao L, Li Y, Kramer PM, Wang W, Pereira MA. 2004. Hypomethylation of DNA and the insulin-like growth factor-II gene in dichloroacetic and trichloroacetic acid-promoted mouse liver tumors. Toxicology 196(1-2):127-136.
66. Tao L, Yang S, Xie M, Kramer PM, Pereira MA. 2000. Effect of trichloroethylene and its metabolites, dichloroacetic acid and trichloroacetic acid, on the methylation and expression of c-Jun and c-Myc protooncogenes in mouse liver: prevention by methionine. Toxicol Sci 54:399-407.
67. Thai SF, Allen JW, DeAngelo AB, George MH, Fuscoe JC. 2001. Detection of early gene expression changes by differential display in the livers of mice exposed to dichloroacetic acid. Carcinogenesis 22:1317-1322.
68. Thai SF, Allen JW, DeAngelo AB, George MH, Fuscoe JC. 2003. Altered gene expression in mouse livers after dichloroacetic acid exposure. Mutat Res 543:167-180.
69. Tzeng HF, Blackburn AC, Board PG, Anders MW. 2000. Polymorphism- and species-dependent inactivation of glutathione transferase zeta by dichloroacetate. Chem Res Toxicol 13(4):231-236.
70. U.S. EPA. 2001. Trichloroethylene Health Risk Assessment: Synthesis and Characterization. External Review Draft Washington, DC:U.S. Environmental Protection Agency, Office of Research and Development. Available: http://oaspub.epa.gov/eims/ eimscomm.getfile?p_download_id=4580 [accessed 3 March 2006].
71. Vaidya VS, Shankar K, Lock EA, Bucci TJ, Mehendale HM. 2003a. Renal injury and repair following S-1,2-dichlorovinyl-L-cysteine administration to mice. Toxicol Appl Pharmacol 188(2):110-121.
72. Vaidya VS, Shankar K, Lock EA, Bucci TJ, Mehendale HM. 2003b. Role of tissue repair in survival from S-(1,2-dichlorovinyl)-L-cysteine-induced acute renal tubular necrosis in the mouse Toxicol Sci 74(1):215-227.
73. Vaidya VS, Shankar K, Lock EA, Dixon D, Mehendale HM. 2004. Molecular mechanisms of renal tissue repair in survival from acute renal tubule necrosis: role of ERK1/2 pathway [published erratum in Toxicol Pathol 31:168-169]. Toxicol Pathol 32(1):604-618.
74. Van de Water B, Houtepen F, Huigsloot M, Tijdens IB. 2001. Suppression of chemically induced apoptosis but not necrosis of renal proximal tubular epithelial (LLC-PK1) cells by focal adhesion kinase (FAK). Role of FAK in maintaining focal adhesion organization after acute renal cell injury. J Biol Chem 276:36183-36193.
75. Voss C, Zerban H, Bannasch P, Berger MR. 2005. Lifelong exposure to di-(2-ethylhexyl)-phthalate induces tumors in liver and testes of Sprague-Dawley rats. Toxicology 206:359-371.
76. Werner H, Le Roith D. 2000. New concepts in regulation and function of the insulin-like growth factors: implications for understanding normal growth and neoplasia. Cell Mol Life Sci 57:932-942.
77. Wideroff L, Gridley G, Mellemkjaer L, Chow WH, Linet M, Keehn S, et al. 1997. Cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark J Natl Cancer Inst 89:1360-1365